Safety and Feasibility Testing of a Smaller Network Version of AIDANET
Part of paid clinical trials in Charlottesville, Virginia.
- Sponsor
- Marc Breton
- Study ID
- NCT06633965
- Status
- Completed
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 60 Years
- Healthy Volunteers
- Not accepted
Interventions
- AIDANET — DEVICEAIDANET is a fully automated, utilizing a Bolus Priming System (BPS) that recognizes meal ingestion and delivers a quick priming dose of insulin prior to extreme blood sugar excursions.
- AIDANET — DEVICEAIDANET is a fully automated, utilizing a Bolus Priming System (BPS) that recognizes meal ingestion and delivers a quick priming dose of insulin prior to extreme blood sugar excursions.
Study Details
A randomized 1:1 crossover trial that intends to demonstrate feasibility and safety of the Automated Insulin Delivery as Adaptive NETwork (AIDANET) system run in a new smaller network version, used in full closed loop (FCL) by adults who have been diagnosed with type 1 diabetes (T1D).
Key Dates
- Start date
- Nov 20, 2024
- Status verified
- Jul 2025
- Primary completion
- Dec 16, 2024
- Completion
- Dec 18, 2024
Study Design
- Enrollment
- 8 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Usual Care→AIDANETParticipants will complete 7 days/6 nights at home usual care period using their personal equipment. Participants will then use the AIDANET system during a 3 days/2 nights hotel admission. Participants will continue to use the AIDANET system at home for 7 days/6 nights.
- Active Comparator: AIDANET→Usual CareParticipants will use AIDANET system during a 3 days/2 nights hotel admission. Participants will continue to use the AIDANET system at home for 7 days/6 nights and then will complete 7 days/6 nights at home usual care period using their personal equipment.
Primary Outcome Measure
Change in the Mean Continuous Glucose Monitor (CGM) Between the Week of the Usual Care Observational Period and the Week of AIDANET At-Home. [ Time Frame: 2 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Virginia | Charlottesville | Virginia | 22904 | - |
Find similar trials in Charlottesville, VA
By condition
By specialty
By research site
Related Studies
- Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 DiabetesRecruiting · University of Virginia · Charlottesville, Virginia
- A Randomized Parallel Clinical Trial of AIDANET, an Automated Insulin Delivery Algorithm, in Fully Closed-Loop Vs Hybrid Closed-Loop Mode In Adults With Type 1 Diabetes (AIDANET At Home)Recruiting · Sue Brown · Charlottesville, Virginia
- SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesPHASE2 · Recruiting · SAb Biotherapeutics, Inc. · San Francisco, California
- Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 DiabetesRecruiting · University of Virginia · Charlottesville, Virginia